Published in Virology on April 30, 1983
The dengue viruses. Clin Microbiol Rev (1990) 4.72
Role of CD8+ T cells in control of West Nile virus infection. J Virol (2004) 3.40
A critical role for induced IgM in the protection against West Nile virus infection. J Exp Med (2003) 2.89
Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J Virol (1989) 2.59
Spontaneous and engineered deletions in the 3' noncoding region of tick-borne encephalitis virus: construction of highly attenuated mutants of a flavivirus. J Virol (1998) 2.11
Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization. PLoS Pathog (2008) 2.00
Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo. J Virol (2001) 1.94
The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization. J Virol (1991) 1.80
Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site. J Virol (2000) 1.77
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection. Expert Rev Mol Med (2008) 1.67
Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence. J Virol (2002) 1.48
A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice. J Virol (2000) 1.46
Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6. J Virol (2001) 1.35
Flavivirus-induced antibody cross-reactivity. J Gen Virol (2011) 1.28
Mimicking live flavivirus immunization with a noninfectious RNA vaccine. Proc Natl Acad Sci U S A (2004) 1.23
Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis. J Virol (1985) 1.23
A single amino acid substitution in envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model. J Virol (1990) 1.19
Spontaneous mutations restore the viability of tick-borne encephalitis virus mutants with large deletions in protein C. J Virol (2003) 1.15
Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein. J Virol (1998) 1.02
Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model. J Virol (1997) 0.98
Immunodominance and functional activities of antibody responses to inactivated West Nile virus and recombinant subunit vaccines in mice. J Virol (2010) 0.95
Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus. J Virol (2005) 0.90
Epitopes functional in neutralization of varicella-zoster virus. J Clin Microbiol (1990) 0.87
Reverse ELISA for the detection of anti West Nile virus IgG antibodies in humans. Eur J Clin Microbiol Infect Dis (2007) 0.80
Specific detection of antibodies to different flaviviruses using a new immune complex ELISA. Med Microbiol Immunol (2011) 0.79
Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen. J Virol (2015) 0.76
Biomarkers in Japanese encephalitis: a review. Biomed Res Int (2013) 0.75
The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature (1995) 12.25
All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood (1990) 4.36
NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood (1991) 4.30
A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science (1997) 4.29
A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1994) 3.97
Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology (1994) 3.82
Proteolytic activation of tick-borne encephalitis virus by furin. J Virol (1997) 3.78
Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J Virol (1995) 3.67
Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation (1999) 3.62
Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol (2001) 3.58
Cloning and expression of a chitinase gene from the hyperparasitic fungus Aphanocladium album. Curr Genet (1992) 3.24
Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus. Mol Cell (2001) 3.23
A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet (1998) 3.09
Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma. Nature (1982) 3.03
Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J Virol (1995) 2.97
Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J Virol (1999) 2.87
Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions. J Virol (1996) 2.75
Cytogenetic studies on African Burkitt's lymphoma cell lines: t(8;14), t(2;8) and t(8;22) translocations. Cancer Genet Cytogenet (1981) 2.74
Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity. J Biol Chem (1995) 2.69
Sequencing the termini of capped viral RNA by 5'-3' ligation and PCR. Biotechniques (1991) 2.64
HIV-1, hepatitis (A,B, and C), and measles in Romanian children. Lancet (1991) 2.63
Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J Virol (1989) 2.59
Sequence of the structural proteins of tick-borne encephalitis virus (western subtype) and comparative analysis with other flaviviruses. Virology (1988) 2.43
Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS). Circulation (1981) 2.36
Chromosomal localization of the human proto-oncogene c-ets. Nature (1984) 2.35
Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia. Proc Natl Acad Sci U S A (2001) 2.35
Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions. J Gen Virol (1991) 2.34
Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis virus. J Virol (1996) 2.33
The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood (1995) 2.30
Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect (2004) 2.30
Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet (1996) 2.26
[4 cases of trisomy for the short arm of chromosome 9. Individualization of a new morbid entity]. Ann Genet (1970) 2.23
Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol (1999) 2.23
The phenomenon of treatment failures in Human African Trypanosomiasis. Trop Med Int Health (2001) 2.18
Spontaneous and engineered deletions in the 3' noncoding region of tick-borne encephalitis virus: construction of highly attenuated mutants of a flavivirus. J Virol (1998) 2.11
Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system. Virology (2000) 2.09
The flavivirus 3'-noncoding region: extensive size heterogeneity independent of evolutionary relationships among strains of tick-borne encephalitis virus. Virology (1995) 2.08
Interferon-gamma production by Listeria monocytogenes-specific T cells active in cellular antibacterial immunity. Eur J Immunol (1983) 2.06
Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest (2001) 2.01
Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo. J Virol (2001) 1.94
Flat Refractive Geometry. IEEE Trans Pattern Anal Mach Intell (2011) 1.90
Homogeneity of the structural glycoprotein from European isolates of tick-borne encephalitis virus: comparison with other flaviviruses. J Gen Virol (1981) 1.90
Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill? Crit Care Med (2003) 1.87
High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood (1995) 1.87
Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias. Genes Chromosomes Cancer (1990) 1.85
Chido and Rodgers blood groups are distinct antigenic components of human complement C4. Nature (1978) 1.85
Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. Am J Hum Genet (1993) 1.83
The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization. J Virol (1991) 1.80
Intrapleural tetracycline for the prevention of recurrent spontaneous pneumothorax. Results of a Department of Veterans Affairs cooperative study. JAMA (1990) 1.79
Infectious cDNA clones of tick-borne encephalitis virus European subtype prototypic strain Neudoerfl and high virulence strain Hypr. J Gen Virol (1997) 1.79
A new congenital dysmegakaryopoietic thrombocytopenia (Paris-Trousseau) associated with giant platelet alpha-granules and chromosome 11 deletion at 11q23. Blood (1995) 1.78
Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site. J Virol (2000) 1.77
Genome sequence of tick-borne encephalitis virus (Western subtype) and comparative analysis of nonstructural proteins with other flaviviruses. Virology (1989) 1.76
In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model. Nat Med (1998) 1.75
[Auditory processing disorders : Consensus statement by the German Society for Phoniatry and Paedaudiology]. HNO (2007) 1.75
Analysis of the pattern of initiation of sustained ventricular arrhythmias in patients with implantable defibrillators. J Cardiovasc Electrophysiol (2000) 1.73
The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed. Nucleic Acids Res (1994) 1.72
Epitope mapping of flavivirus glycoproteins. Adv Virus Res (1986) 1.67
Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency. Lancet (2004) 1.64
Smoking and mental illness. Pharmacol Biochem Behav (2001) 1.63
Secondary structure of the 3'-noncoding region of flavivirus genomes: comparative analysis of base pairing probabilities. RNA (1997) 1.62
A model study of the use of monoclonal antibodies in capture enzyme immunoassays for antigen quantification exploiting the epitope map of tick-borne encephalitis virus. J Biol Stand (1986) 1.62
FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte. J Hepatol (2001) 1.60
A review of the research on general health status indexes. Med Care (1975) 1.58
Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged. Infect Immun (1981) 1.57
Self-induced correction of the genetic defect in tyrosinemia type I. J Clin Invest (1994) 1.57
Age of bed v, olduvai gorge, Tanzania. Science (1968) 1.54
Complete genomic sequence of Powassan virus: evaluation of genetic elements in tick-borne versus mosquito-borne flaviviruses. Virology (1993) 1.54
Demonstration of IgA polioantibody in saliva, duodenal fluid and urine. Nature (1967) 1.53
Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells. Blood (2000) 1.52
Differential effects of exercise training intensity on blood pressure and cardiovascular responses to stress in borderline hypertensive humans. J Hypertens (1996) 1.51
Nuclear membrane protein LAP2beta mediates transcriptional repression alone and together with its binding partner GCL (germ-cell-less). J Cell Sci (2001) 1.51
Establishment of PCR for the early diagnosis of herpes simplex encephalitis. J Med Virol (1990) 1.50
Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing. Clin Pharmacol Ther (2013) 1.49
A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukemia. Blood (1995) 1.48
AF6q21, a novel partner of the MLL gene in t(6;11)(q21;q23), defines a forkhead transcriptional factor subfamily. Blood (1997) 1.47
Large daily fluctuations in plasma tyrosine in treated patients with phenylketonuria. Am J Clin Nutr (1996) 1.47
Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations. Genes Chromosomes Cancer (1995) 1.46
Loss of a histidine residue at the active site of S-locus ribonuclease is associated with self-compatibility in Lycopersicon peruvianum. Proc Natl Acad Sci U S A (1994) 1.46